BioImagene's new Digital Pathology Workstation launched at CAP ‘09 meeting

BioImagene, Inc., the leading provider of innovative digital pathology solutions, launched Crescendo – the new Digital Pathology Workstation (DPW) at the CAP ’09 – THE Pathologists’ Meeting™. The meeting is taking place from October 11 - 14, 2009 in the Gaylord National Harbor in Washington D.C.

The Crescendo was launched amid fanfare in front of a packed audience on October 11 at 9:39 a.m. by Dr. Ajit Singh, chief executive officer of BioImagene. He commented, “Crescendo, analogous to its musical namesake, is at the pinnacle of diagnostic intelligence. It is an integrated platform that brings together diagnostic information from all relevant sources, including anatomical pathology, clinical pathology, radiology, molecular medicine, and facilitates efficient and effective diagnosis, collaboration and decision support.”

Crescendo DPW aids in transforming the role of a pathologist into that of a diagnostician. It polls data from silos such as laboratory information systems (LIS), radiology picture archiving and communication systems (PACS), gross images, online references (e.g., PathXchange.org), and differential patient information to provide pathologists with all the relevant information at their fingertips. Crescendo is a modern-day companion for the pathologists, custom designed to ensure maximum productivity.

Richard C. Friedberg, M.D., Ph.D., chairman of the department of pathology at Baystate Health in Springfield, Mass., commented “With the advent of digital pathology, all the relevant diagnostic information can be displayed side-by-side, to provide the most complete and accurate diagnostic picture for an individual patient. The promise of Crescendo is to integrate the various diagnostic disciplines into a true diagnostic workstation.”

Attendees can view live demonstrations of the Crescendo at BioImagene’s Booth 411 at the CAP ‘09 meeting.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New biomarker could help predict Parkinson’s disease progression